Pediatrix Medical Group to report Q2 2025 results with focus on operational performance, regulatory compliance, and revenue cycle management strategies impacting healthcare insurers and providers.

Post-Helene storm, Western North Carolina confronts significant healthcare, funding, and economic challenges due to federal Medicaid cuts, SNAP reductions, and rising insurance costs.

U.S. health care costs continue to outpace economic growth, prompting increased interest in alternative models like Samaritan Ministries health care sharing, offering flexibility and cost savings amid rising insurance premiums.

Tennessee's ACA health insurance premiums are set to rise by 15% in 2026 due to expiring tax credits and rising medical costs. Learn about the regulatory changes and impact on employer-sponsored insurance.

Cigna Group navigates rising medical costs, specialty drug expenses, and mixed trading signals as analysts maintain a positive outlook amid sector-wide challenges.

Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.

Prescription drug denials by private insurers rise 25% (2016-2023). Sarepta gene therapy linked to patient deaths. ICE gains Medicaid data access. ACA insurers seek 2026 rate hikes. Implications for U.S. insurance, regulatory compliance, and patient access.

Oscar Health's innovative routing technology is driving claims deflation and profitability, reshaping healthcare delivery and insurance cost management in the U.S. market.

Maris Kreizman shares insights on the evolving U.S. publishing industry, freelance writing challenges, health insurance issues for creatives, and critiques of corporate media structures.

Research reveals immune checkpoint inhibitors improve cancer survival rates but widen insurance-based disparities. Expanding health coverage may mitigate gaps in treatment outcomes.